CTAPIII/CXCL7: a novel biomarker for early diagnosis of lung cancer

Publisher： John Wiley & Sons Inc

E-ISSN： 2045-7634|7|2|325-335

ISSN： 2045-7634

Source： Cancer Medicine, Vol.7, Iss.2, 2018-02, pp. : 325-335

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A smoking-associated 7-gene signature for lung cancer diagnosis and prognosis

By                    

International Journal of Oncology, Vol. 41, Iss. 4, 2012-01 ,pp. : 1387-1396

Spandidos Publications

Access to resources Recommend Favorite

FAM83B is a novel biomarker for diagnosis and prognosis of lung squamous cell carcinoma

By  

International Journal of Oncology, Vol. 46, Iss. 3, 2015-01 ,pp. : 999-1006

Spandidos Publications

Access to resources Recommend Favorite

Early clinical diagnosis of synchronous multiple primary lung cancer

By                

Oncology Letters, Vol. 3, Iss. 1, 2012-01 ,pp. : 234-237

Spandidos Publications

Access to resources Recommend Favorite

Potential molecular approaches for the early diagnosis of lung cancer (Review)

By Oak Chul Ho   Wilson Donald   Lee Hu Jang   Lim Ho-Ju   Park Eun-Kee  

Molecular Medicine Reports, Vol. 6, Iss. 5, 2012-11 ,pp. : 931-936

Spandidos Publications

Access to resources Recommend Favorite

Autoantibodies against insulin-like growth factorbinding protein-2 as a serological biomarker in the diagnosis of lung cancer

By                

International Journal of Oncology, Vol. 42, Iss. 1, 2013-01 ,pp. : 93-100

Spandidos Publications

Access to resources Recommend Favorite